CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics Max Pain By Strike
CRSP trades at $57.61, pinned near the near-term max pain of $58 expiring Aug 22, 2025 (3 days). Price stability likely with balanced options positioning at this level. Max pain is stable across expirations ($40-$70), indicating stable market expectations. Key magnetic zone at 58 where 3 expirations converge.
CRISPR Therapeutics Max Pain By Expiry
Max pain for CRSP shows stable levels around 54.42, reflecting balanced market expectations. The 55% spread signals divergent expectations across timeframes. Levels distributed around 57.61. Strong magnetic level at 58 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 22, 2025 | 58 | 0.39 (0.68%) |
| Aug 29, 2025 | 58 | 0.39 (0.68%) |
| Sep 5, 2025 | 57 | -0.61 (-1.06%) |
| Sep 12, 2025 | 57 | -0.61 (-1.06%) |
| Sep 19, 2025 | 60 | 2.39 (4.15%) |
| Sep 26, 2025 | 55 | -2.61 (-4.53%) |
| Oct 17, 2025 | 50 | -7.61 (-13.21%) |
| Dec 19, 2025 | 70 | 12.39 (21.51%) |
| Jan 16, 2026 | 47.5 | -10.11 (-17.55%) |
| Apr 17, 2026 | 47.5 | -10.11 (-17.55%) |
| Jun 18, 2026 | 57.5 | -0.11 (-0.19%) |
| Sep 18, 2026 | 50 | -7.61 (-13.21%) |
| Jan 15, 2027 | 40 | -17.61 (-30.57%) |